VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: squetch who wrote (4149)	2/19/1998 5:22:00 PM
From: Biomaven	of 9719

I've been taking a look at NTII, currently exiled to the BB. Consider the following table in the report they just released: ntii.com Diabetic Patient Self-Assessment of Nocturnal Pain Measured on Visual Analogue Scale (VAS) of 1-100 8th Week of Treatment Memantine Placebo Number of Patients 28 37 Mean Nocturnal Pain Rating 31.2 44.4 Median Nocturnal Pain Rating 23.6 47.3 P-Value = .073 --------- So what we have here is that the median dropped much more than the mean. That indicates to me that there is probably a large subgroup for which it worked very well and another subgroup for which it did nothing much. Am I reading too much into the tea-leaves of a very empty cup? The stock looks tempting at these levels, except for the wicked spread and that little comment about running out of money in March... The stock price has been unchanged for about a week now, except for the bid/ask ping-pong. My gut tells me that they'll come up with something to keep them going, that Memantine will be partnered and the stock is a buy. My head tells me to put itself under a pillow until the feeling goes away ... Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next